Latest news
Philadelphia's BriaCell Gets FDA Clearance to Take Its Cancer Immunotherapy Platform Into Prostate Cancer - BioBuzzBioBuzz · Fri, 07 Aug 2026 15:36:03 GMTFDA Clears Bria-PROS+ Immunotherapy Trial in Prostate Cancer - Targeted OncologyTargeted Oncology · Fri, 07 Aug 2026 00:45:35 GMTBriaCell Receives FDA Clearance to Initiate Bria-PROS+ Clinical Study in Prostate Cancer - Investing News NetworkInvesting News Network · Wed, 05 Aug 2026 12:47:14 GMTBriaCell Receives FDA Clearance to Initiate Bria-PROS+™ Clinical Study in Prostate Cancer - GlobeNewswireGlobeNewswire · Wed, 05 Aug 2026 11:30:00 GMTFDA clearance lets BriaCell test personalized prostate immunotherapy - Stock TitanStock Titan · Wed, 05 Aug 2026 11:30:00 GMT